Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Health Outcomes Associates Ltd,Abiraterone,"Prostate cancer, same indications as for originator",Abiraterone (Yonsa),Community,
